Last reviewed · How we verify
NCT07039591
Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlanta, GA
EARLY_PHASE1 trial testing Pro-type IVR in Contraceptive Usage in 60 participants. Currently enrolling.
30 April 2026
Quick facts
| Lead sponsor | Population Council |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 8 August 2025 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 October 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pro-type IVR
Conditions studied
- Contraceptive Usage — all drugs for Contraceptive Usage →
Sponsor
Population Council
Who can join
Adults 18 to 49, female only, with Contraceptive Usage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized open label crossover trial to assess performance attributes and acceptability of non-medicated intravaginal rings among sexually active women in Atlanta, GA
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07039591
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contraceptive Usage
Currently open trials in the same condition.
- NCT06682065 — Telemedicine Contraceptive Counselling (TECC) Versus Standard Care · NA · recruiting
- NCT05674513 — Disparities in Emergency Contraceptive Metabolism Dictate Efficacy · Phase 4 · recruiting
- NCT04558229 — RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users · Phase 4 · active not recruiting
- NCT03984695 — Sexual Health Empowerment for Women's Health · NA · active not recruiting
Other Population Council trials
Trials by the same sponsor.
- NCT04778514 — A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention · NA · completed
- NCT05644886 — Pilot Study on Engaging Family Physicians in Family Planning in Pakistan · NA · unknown
- NCT04778527 — A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention · NA · unknown
- NCT05128136 — A Crossover Study Evaluating 3 Non-medicated Silicone IVRs · NA · completed
- NCT02875119 — Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07039591 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Population Council
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07039591.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing